MEDACTA GROUP SA

Consensus Medacta Group SA

Equities

MOVE

CH0468525222

Market Closed - Swiss Exchange Other stock markets 11:31:25 2023-12-04 am EST			5-day change	1st Jan Change
113.8 ^CHF	-2.57%		-4.37%	+10.49%

Nov. 30	Medacta to Expand Swiss Facilities to Boost Production Capacity	MT
Oct. 30	Medacta Group to Launch Optimized Knee Implant	MT

Evolution of the average Target Price on Medacta Group SA

Price target over the last 5 years

History : Analyst Recommendations

b3fabfd9b5a8d03d9b1f6b.9X3IC1yYqEusfifI-lJbBD_BfzggJEefasz9JjSvcLU.hxyKQSvynB6aMhSjkCUOVGWeJV54XS_uBKaMQX79KvO9Fb5hbOHcBJgrSA~4122b6907306b013df30bbdd103be322

Analyst Recommendations on Medacta Group SA

Octavian Lifts Price Target on Medacta Group, Maintains Buy Recommendation	Feb. 06	MT
MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral Recommendation	2021	MT
MEDACTA : Octavian Lifts Price Target on Medacta Group, Maintains Buy Recommendation	2021	MT
MEDACTA : Octavian Lifts Price Target on Medacta Group, Maintains Buy Recommendation	2021	MT
MEDACTA : Morgan Stanley Lifts Price Target on Medacta Group, Maintains Equalweight/In-Line Recommendation	2020	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

5

Last Close Price

120.43EUR

Average target price

137.58EUR

Spread / Average Target

+14.24%

High Price Target

162.28EUR

Spread / Highest target

+34.75%

Low Price Target

118.08EUR

Spread / Lowest Target

-1.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medacta Group SA

Octagon Capital
Credit Suisse

Ratings for Medacta Group SA

Trading Rating :

Investor Rating :

ESG Refinitiv :

B

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer